European Archives - Page 909 of 1020 - European Medical Journal

Continue
EMJ
8 Feb 2016

Plant Protein Reduces Mortality Risk in Chronic Kidney Disease Patients

RESEARCH from the University of Utah School of Medicine (UUSOM) has demonstrated that consuming a high plant-based to total protein ratio can…
EMJ
5 Feb 2016

Roles of targeted therapy and immunotherapy for gastrointestinal cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Atsushi Ohtsu, MD, PhD…
EMJ
5 Feb 2016

ESMO 2015 highlights: Putting ovarian cancer management into perspective

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes…
EMJ
5 Feb 2016

Defining ESMO Clinical Practice Guidelines at ESMO Asia 2015

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes, MD…
EMJ
5 Feb 2016

Phase 1b trial of durvalumab plus tremelimumab for advanced non-small cell lung cancer

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste…
EMJ
5 Feb 2016

Update from CheckMate 057: Nivolumab versus docetaxel in advanced non-squamous NSCLC

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste, MD…
EMJ
5 Feb 2016

Therapeutic advances in immune checkpoint inhibitors for head and neck cancers

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
EMJ
5 Feb 2016

KEYNOTE-028: Phase 1b trial of pembrolizumab in PD-L1-positive nasopharyngeal carcinoma

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
EMJ
5 Feb 2016

LUX-H&N1: Phase 3 trial of afatinib versus methotrexate for head and neck squamous cell carcinoma

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
EMJ
5 Feb 2016

ESMO Clinical Practice Guidelines: Breast cancer case presentation

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Fatima Cardoso, MD, from…